Table 1.
Clinicopathological factors | Number (n=105) | Relative expression | P value | |
---|---|---|---|---|
Low (n=74) | High (n=31) | |||
Gender | 0.608 | |||
Male | 58 | 39 | 19 | |
Female | 47 | 35 | 12 | |
Age | 0.616 | |||
≤ 60 | 43 | 28 | 15 | |
> 60 | 62 | 46 | 16 | |
Size (cm) | 0.211 | |||
≤ 5 | 41 | 36 | 5 | |
> 5 | 64 | 38 | 26 | |
TNM stage | 0.009 | |||
I, II | 59 | 32 | 27 | |
III, IV | 46 | 42 | 4 | |
Lymphatic metastasis | 0.004 | |||
NO | 81 | 58 | 23 | |
YES | 24 | 16 | 8 | |
Distant metastasis | 0.013 | |||
NO | 75 | 51 | 24 | |
YES | 30 | 23 | 7 | |
Recurrence | 0.051 | |||
NO | 79 | 53 | 26 | |
YES | 26 | 21 | 5 |
High and low expression of UQCRC2 protein was defined according to the cut-off value of 4 for immunoreactivity score (IS).